Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
2001 2
2003 4
2004 1
2005 6
2006 1
2007 3
2008 7
2009 8
2010 12
2011 13
2012 14
2013 17
2014 18
2015 20
2016 16
2017 23
2018 22
2019 17
2020 17
2021 18
2022 11
2023 18
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

259 results

Results by year

Filters applied: . Clear all
Page 1
Feasibility, safety, and impact of the RTS,S/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.
Asante KP, Mathanga DP, Milligan P, Akech S, Oduro A, Mwapasa V, Moore KA, Kwambai TK, Hamel MJ, Gyan T, Westercamp N, Kapito-Tembo A, Njuguna P, Ansong D, Kariuki S, Mvalo T, Snell P, Schellenberg D, Welega P, Otieno L, Chimala A, Afari EA, Bejon P, Maleta K, Agbenyega T, Snow RW, Zulu M, Chinkhumba J, Samuels AM; Malaria Vaccine Programme Evaluation Partners. Asante KP, et al. Lancet. 2024 Apr 27;403(10437):1660-1670. doi: 10.1016/S0140-6736(24)00004-7. Epub 2024 Apr 4. Lancet. 2024. PMID: 38583454 Clinical Trial.
How PrEP delivery was integrated into public ART clinics in central Uganda: A qualitative analysis of implementation processes.
Wyatt MA, Pisarski EE, Nalumansi A, Kasiita V, Kamusiime B, Nalukwago GK, Thomas D, Muwonge TR, Mujugira A, Heffron R, Ware NC; Partners PrEP Program Study Team. Wyatt MA, et al. PLOS Glob Public Health. 2024 Mar 7;4(3):e0002916. doi: 10.1371/journal.pgph.0002916. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 38452111 Free PMC article.
Behavioral Modeling and its Association with PrEP and ART Use in Ugandan HIV-Serodifferent Couples.
Wang L, Muwonge TR, Simoni JM, Nambi F, Nakabugo L, Kibuuka J, Thomas D, Katz IT, Feutz E, Thomas KK, Ware NC, Wyatt MA, Kadama H, Mujugira A, Heffron R; Partners PrEP Program Study Team. Wang L, et al. AIDS Behav. 2024 May;28(5):1719-1730. doi: 10.1007/s10461-024-04286-2. Epub 2024 Feb 16. AIDS Behav. 2024. PMID: 38361169 Free PMC article. Clinical Trial.
Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults.
Zhang Y, Romieu-Hernandez A, Boehmer TK, Azziz-Baumgartner E, Carton TW, Gundlapalli AV, Fearrington J, Nagavedu K, Dea K, Moyneur E, Cowell LG, Kaushal R, Mayer KH, Puro J, Rasmussen SA, Thacker D, Weiner MG, Saydah S, Block JP; PCORnet Network Partners. Zhang Y, et al. BMC Infect Dis. 2024 Feb 10;24(1):181. doi: 10.1186/s12879-024-09076-8. BMC Infect Dis. 2024. PMID: 38341566 Free PMC article.
Evaluation of the implementation of a community health worker-led COVID-19 contact tracing intervention in Chiapas, Mexico, from March 2020 to December 2021.
Aranda Z, Vázquez S, Gopaluni A, Martínez L, Ramírez M, Jiménez A, Bernal D, Rodríguez AL, Chacón S, Vargas B, Fulcher IR, Barnhart DA; Partners In Health Cross-Site COVID-19 Cohort Technical Working Group. Aranda Z, et al. BMC Health Serv Res. 2024 Jan 18;24(1):97. doi: 10.1186/s12913-024-10590-3. BMC Health Serv Res. 2024. PMID: 38233915 Free PMC article.
Intimate Partner Violence and Adherence to PrEP and ART Among Ugandan HIV Serodifferent Couples.
Thomas D, Nakabugo L, Nambi F, Kibuuka J, Muwonge TR, Feutz E, Thomas KK, Simoni JM, Montgomery ET, Ware N, Wyatt MA, Katz IT, Kadama H, Mujugira A, Heffron R; Partners PrEP Program Team. Thomas D, et al. J Acquir Immune Defic Syndr. 2024 Apr 1;95(4):347-354. doi: 10.1097/QAI.0000000000003368. J Acquir Immune Defic Syndr. 2024. PMID: 38133584 Free PMC article.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
259 results